Skip to main content

Disclaimer

In the Downloads section, the ‘Prior Submission’ file reflects the most recent measure submission to the former CBE. This file is provided for transparency. For any questions or clarification, please contact the designated measure steward.

Concurrent Use of Opioids and Benzodiazepines (COB)

CBE ID
3389
Endorsement Status
Endorsed
1.0 New or Maintenance
Maintenance
1.1 Measure Structure
Single Measure
Previous Endorsement Cycle
Spring 2021
Is Under Review
No
Next Maintenance Cycle
Spring 2027
1.6 Measure Description

The percentage of individuals >=18 years of age with concurrent use of prescription opioids and benzodiazepines during the measurement year.

A lower rate indicates better performance.

Measure Specs
General Information
1.7 Measure Type
Process
1.3 Electronic Clinical Quality Measure (eCQM)
No
1.8 Level of Analysis
Health Plan
1.20 Types of Data Sources
Claims Data
1.14 Numerator

The number of individuals from the denominator with concurrent use of opioids and benzodiazepines for >=30 cumulative days during the measurement year.

1.15 Denominator

The denominator includes individuals >=18 years of age with >=2 prescription claims for opioid medications on different dates of service and with >=15 cumulative days’ supply during the measurement year. Individuals with cancer, sickle cell disease, or in hospice are excluded.

Exclusions

Individuals with cancer, sickle cell disease, or in hospice at any point during the measurement year are excluded from the denominator.

1.13 Data Dictionary
Not attached. I attest that all information will be provided where codes and/or value sets are needed (1.14a - 1.15c).
Most Recent Endorsement Activity
Endorsed Patient Safety Spring Cycle 2021
Initial Endorsement
Last Updated
Steward Organization
Pharmacy Quality Alliance
Steward POC email
[email protected]
Steward Organization URL
https://www.pqaalliance.org/
Steward Organization Copyright

COPYRIGHT 2021 PQA, INC. ALL RIGHTS RESERVED

Risk Adjustment
No risk adjustment or risk stratification
Use
6.1.2 Current or Planned Use(s)
Public Reporting
6.1.3 Current or Planned Use(s)
Public Reporting
Public Comments